CVS Health Corporation (ETR:CVS)
Germany · Delayed Price · Currency is EUR 66.95
+0.30 (0.45%)
Oct 10, 2025, 5:35 PM CET
CVS Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2010 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2010 - 2019 |
Changes in Other Operating Activities | 7,568 | 9,107 | 13,426 | 16,177 | 18,265 | 15,865 | Upgrade |
Operating Cash Flow | 7,568 | 9,107 | 13,426 | 16,177 | 18,265 | 15,865 | Upgrade |
Operating Cash Flow Growth | -6.24% | -32.17% | -17.01% | -11.43% | 15.13% | 23.48% | Upgrade |
Capital Expenditures | -2,788 | -2,781 | -3,031 | -2,727 | -2,520 | -2,437 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | - | - | 101 | Upgrade |
Purchases of Investments | -15,596 | -15,191 | -9,043 | -7,746 | -9,963 | -9,639 | Upgrade |
Proceeds from Sale of Investments | 12,801 | 10,353 | 7,729 | 6,729 | 7,246 | 6,467 | Upgrade |
Payments for Business Acquisitions | -161 | -95 | -16,612 | -139 | -146 | -866 | Upgrade |
Proceeds from Business Divestments | - | - | - | -1,249 | - | 840 | Upgrade |
Other Investing Activities | 64 | 101 | 68 | 85 | 122 | - | Upgrade |
Investing Cash Flow | -5,680 | -7,613 | -20,889 | -5,047 | -5,261 | -5,534 | Upgrade |
Short-Term Debt Issued | 3,040 | 1,919 | 5,200 | - | - | - | Upgrade |
Short-Term Debt Repaid | - | - | -5,000 | - | - | - | Upgrade |
Net Short-Term Debt Issued (Repaid) | 3,040 | 1,919 | 200 | - | - | - | Upgrade |
Long-Term Debt Issued | - | 7,913 | 10,898 | - | 987 | 9,958 | Upgrade |
Long-Term Debt Repaid | -5,498 | -4,773 | -3,166 | -4,211 | -10,254 | -15,631 | Upgrade |
Net Long-Term Debt Issued (Repaid) | -5,498 | 3,140 | 7,732 | -4,211 | -9,267 | -5,673 | Upgrade |
Issuance of Common Stock | 324 | 361 | 277 | 551 | 549 | 264 | Upgrade |
Repurchase of Common Stock | -134 | -3,208 | -2,193 | -3,870 | -168 | -88 | Upgrade |
Net Common Stock Issued (Repurchased) | 190 | -2,847 | -1,916 | -3,319 | 381 | 176 | Upgrade |
Common Dividends Paid | -3,381 | -3,373 | -3,132 | -2,907 | -2,625 | -2,624 | Upgrade |
Other Financing Activities | 11 | 26 | -201 | -79 | 155 | 425 | Upgrade |
Financing Cash Flow | -2,683 | -1,135 | 2,683 | -10,516 | -11,356 | -7,696 | Upgrade |
Net Cash Flow | -795 | 359 | -4,780 | 614 | 1,648 | 2,635 | Upgrade |
Beginning Cash & Cash Equivalents | 12,820 | 8,525 | 13,305 | 12,691 | 11,043 | 8,408 | Upgrade |
Ending Cash & Cash Equivalents | 12,025 | 8,884 | 8,525 | 13,305 | 12,691 | 11,043 | Upgrade |
Free Cash Flow | 4,780 | 6,326 | 10,395 | 13,450 | 15,745 | 13,428 | Upgrade |
Free Cash Flow Growth | -24.44% | -39.14% | -22.71% | -14.58% | 17.26% | 29.23% | Upgrade |
FCF Margin | 1.24% | 1.71% | 2.91% | 4.18% | 5.41% | 5.01% | Upgrade |
Free Cash Flow Per Share | 3.78 | 5.01 | 8.06 | 10.17 | 11.85 | 10.22 | Upgrade |
Levered Free Cash Flow | 6,853 | 15,999 | 26,671 | 13,550 | 14,479 | 14,934 | Upgrade |
Unlevered Free Cash Flow | 10,520 | 11,072 | 19,824 | 18,726 | 24,927 | 23,093 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.